Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar SteveTheBluesman (93.90) Submitted: 3/16/2009 9:46:58 AM : Outperform Start Price: $18.05 OSIR Score: -140.24

The only stem company that makes money. Huge deal with Genzyme. They are ready to double.

Report this Post 1 Comment
Member Avatar goldminingXpert (99.72) Submitted: 4/8/2009 4:19:38 PM
Recs: 0

"The only stem company that makes money."That's a lie. They haven't EVER made a profit."Huge deal with Genzyme"That's a bigger lie."They are ready to double."There's a place in the penny-stock touting circle of hell waiting for you, you spineless garbage-touting POS.(GMX has no position in OSIR.)

Featured Broker Partners


Advertisement